Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians

BACKGROUND: There is little published information on baseline characteristics and therapeutic outcomes in hepatitis C virus (HCV)-infected Aboriginal Canadians. It is unclear what proportion of HCV-infected Aboriginal people receive therapy relative to other populations.

Détails bibliographiques
Auteurs principaux: Curtis L Cooper, Robert J Bailey, Vince G Bain, Frank Anderson, Eric M Yoshida, Mel Krajden, Paul Marotta, for the Canadian Pegasys Study Group
Format: Article
Langue:English
Publié: Wiley 2008-01-01
Collection:Canadian Journal of Gastroenterology
Accès en ligne:http://dx.doi.org/10.1155/2008/320150